Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-02
1989-11-07
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548504, C07D20916, A61K 31405
Patent
active
048793051
ABSTRACT:
This invention relates to pharmacologically-active novel compounds comprising .beta.-fluoromethylene-5-hydroxytryptophan and derivatives, to methods of inhibiting monoamine oxidase and to treating depression, and to pharmaceutical compositions containing the compounds.
REFERENCES:
patent: 3037031 (1962-05-01), Lewis
patent: 3168526 (1965-02-01), Heinzelman et al.
Collard Jean-Noel
McDonald Ian A.
Palfreyman Michael G.
Merrell Dow Pharmaceuticals
Springer David B.
Wille Louis J.
LandOfFree
Use of .beta.-(fluoromethylene)-5-hydroxytryptophan and derivati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of .beta.-(fluoromethylene)-5-hydroxytryptophan and derivati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of .beta.-(fluoromethylene)-5-hydroxytryptophan and derivati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-84099